Travoprost 0.004% once daily provides effective IOP-lowering efficacy with significantly greater IOP reduction from baseline when compared with pilocarpine 1% 4 times daily at 4 PM over the 12-week period. Travoprost 0.004% once daily is safe and well tolerated in PAC or PACG patients.
Based on the random questionnaire survey of the elderly in Haikou, Hainan Province in the first half of 2018. This paper analyzes the elderly people's willingness and its influencing factors by using single factor interaction analysis and non-sequential multi-classification Logistic regression model. The results show that the old-age pension of the majority of the elderly doesn't depend on the degree of filial piety of the children, and the number of children, the socialized pension service factors and the attitude of the old-age care have different effects on the choice of the elderly.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.